Arcus Biosciences
RCUS
#4300
Rank
HK$21.54 B
Marketcap
HK$149.65
Share price
4.40%
Change (1 day)
-1.11%
Change (1 year)
Categories

Operating Margin for Arcus Biosciences (RCUS)

Operating Margin as of November 2026 (TTM): -393.16%

According to Arcus Biosciences 's latest financial reports and stock price the company's current Operating Margin is -393.16%. At the end of 2021 the company had an Operating Margin of 14.27%.

Operating Margin history for Arcus Biosciences from 2018 to 2022

Operating Margin at the end of each year

Year Operating Margin Change
202114.27%-109%
2020-158.49%-71.94%
2019-564.73%-4.88%
2018-593.73%-84.2%
2017-3,756.69%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
ORIC Pharmaceuticals
ORIC
0.00%N/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.